Tag: Claret Medical
Claret Medical closes US$14.5 million in Series C financing to extend...
Claret Medical, developer of the Sentinel cerebral protection system, has closed on a Series C financing of US$14.5 million led by Lightstone Ventures, with participation...
Reduced stroke and mortality with cerebral protection use in TAVI patients
A new study published in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions underscores the role of the Sentinel Cerebral Protection System (Claret...
Sentinel becomes first cerebral protection device to receive FDA approval
Claret Medical has received regulatory clearance from the FDA for its Sentinel cerebral protection system, via de novo classification, meaning that the device can...
